[144] Itron Inc SEC Filing
Itron Inc (ITRI) reported a Form 144 notice for the proposed sale of 970 common shares, acquired through restricted stock vesting on 08/22/2025 as compensation. The shares are to be sold approximately on 08/25/2025 through Fidelity Brokerage Services LLC, with an aggregate market value reported as $121,547.88. The filing shows 45,717,933 shares outstanding, which places the planned sale at a very small fraction of the outstanding stock. The filer also disclosed a prior sale by Joan S. Hooper of 938 shares on 05/27/2025 generating $107,818.50 in gross proceeds.
- Full Rule 144 fields disclosed: acquisition date, nature of acquisition, payment type, broker, intended sale date, and aggregate market value are provided
- Transaction size is immaterial relative to 45,717,933 shares outstanding (970 shares proposed to sell)
- Sale routed through a major broker (Fidelity Brokerage Services LLC), indicating standard execution and settlement processes
- Insider sale in prior three months: Joan S. Hooper sold 938 shares on 05/27/2025, which may attract investor attention despite small size
Insights
TL;DR: Small, routine insider sale from vested compensation; not materially dilutive given outstanding share count.
The filing documents a proposed sale of 970 shares acquired via restricted stock vesting and designated as compensation. Relative to the reported 45.7 million shares outstanding, the position is immaterial in size. The sale is routed through a major broker, suggesting a standard execution pathway. Recent prior sale of 938 shares by Joan S. Hooper is disclosed, indicating some recent insider liquidity but limited scale. No undisclosed material information is asserted in the notice.
TL;DR: Filing meets Rule 144 disclosure elements; provides acquisition, payment, and broker details required for compliance.
The Form 144 includes acquisition date, nature (restricted stock vesting), payment characterization (compensation), broker details, intended sale date, and aggregate market value, satisfying key Rule 144 notice elements. The signer attests to absence of undisclosed material adverse information. No indications of complex consideration arrangements or aggregation issues are present in the disclosed rows. Documentation appears routine from a regulatory-compliance perspective.